 |
|
|
|
 |
| JULY 23 ,
2009 | ISSUE NUMBER 108 VOL 6 |
Emerging Markets
The Pharmerging Future
A dramatic shift is underway in terms of where the global pharmaceutical industry is turning for growth and profitability. Raymond Hill and Mandy Chui of IMS Health highlight the emerging markets that will provide value and opportunities as the global pharma market matures.
Marketing
Relationship Marketing Study Breaks Down Online Drug Convo
It’s no secret that consumers are getting chatty online about healthcare. Razorfish breaks down which drug scores the highest in terms of positive sentiment amid Web jabber.
Government
New NIH Leader Backs Personalized Medicine
Collins seeks to parlay genomic discoveries into new biomedical therapies. Comparative effectiveness research, he says, should identify subpopulation responses to treatment and support personalized medicine.
Global
Statins Get Boost from New Study
Statins should be given to people with high blood pressure or diabetes, even if they don’t have heart disease, according to a study published in the British Medical Journal.
R&D
The Rx for R&D
The process of research and development of new drugs has become phenomenally expensive. Can Lean Six Sigma revitalize the innovation process for pharmaceutical companies?
Strategy
Prepare Now to Avoid the Burn
The sponsors of clinical trials Sunshine Act legislation are asking for a lot of new rules in the name of transparency. Sondra Pepe looks at what pharma companies can do to ready themselves for the new regulations.
 
|
 |
|  HC&B Healthcare Communications made Darren Fuller senior account executive // Fact Flow Research made Vernon J. Grubisich senior research director // Altum appointed Don Martiny to executive vice president, chief creative officer // Chimerix appointed Kenneth I. Moch to chief operating officer //
Piedmont Pharmaceuticals appointed Michael Kelly to chief financial officer // ECI Healthcare made Robin Raff director of strategy // AbelsonTaylor hired Andrew Anderson, Syed Ahmed, and Sabrina Cua as clinical research associates // Cornerstone Therapeutics’ David Price, executive vice president, finance, and chief financial officer, was named Triangle Business Journal’s CFO of the year in the small public business category //
|
 |
|
|
|
July
30–31 CBI’s
4th Clinical Supply Chain Management Conference,
Princeton, NJ
August
11–22 3rd Annual Forum on Tracking State Laws and Aggregate Spend,
Arlington, VA
September
14–15 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry,
Philadelphia, PA
September
21–24 5th
Annual Process Excellence Week for the Service & Transactional
World, Chicago, IL
September
30 Prix Galien 2009 Awards Ceremony, New York, NY
October
5–7 BioNetwork
2009: The 7th Annual Pharmaceutical-Biotech Partnering
Conference, Laguna Niguel, California |
 |
|
|
 |
|
 |
|
 |
| Should the Department of Justice end pharma’s tactic of paying off other firms to postpone generic competition? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
